SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-08
👔
Apogee Therapeutics, Inc.
@APGE_InsiderForm 4 Filing: Dambkowski Carl Sells $832,232.5 of $APGE
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Apogee Therapeutics, Inc.
Ticker: $APGE
Transaction Value
$832,232.5
Price/Share: $86.47
transaction date
2026-08-05
Shares: 9,625
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Dambkowski Carl, holds the title of Chief Medical Officer at Apogee Therapeutics, Inc..
On 2026-08-05, the insider transacted 9,625 shares.The shares were transacted at a weighted average price of $86.47 per share, resulting in a total market-relevant value of $832,232.5.
Executive Summary Summary
Dambkowski Carl (Chief Medical Officer) sold $832K of $APGE
Post-Transaction Position: 168,498 shares
SEC Accession No: 0001104659-26-092838 (CIK: 1983476)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.